View Post

Internal Mammary Node Irradiation May Benefit Some Breast Cancer Patients

In In The News by Barbara Jacoby

By: Leah Lawrence From: cancertherapyadvisor.com Internal mammary node irradiation (IMNI) may benefit patients with node-positive breast cancer who have mediocentrally located tumors, according to phase 3 results published in JAMA Oncology. However, the study also suggests that IMNI does not significantly benefit patients with node-positive breast cancer overall. This phase 3 trial (ClinicalTrials.gov Identifier: NCT04803266) was conducted to determine if …

View Post

Trial results extend add to uses for Exact Sciences test

In Clinical Studies News by Barbara Jacoby

By: Joel Berg From: medcitynews.com The genomic test, known as Oncotype DX, can help predict whether women with certain forms of breast cancer will benefit from chemotherapy — and those who won’t. The latest trial results extend the test’s reach. A clinical trial shows that a genomic test from diagnostics company Exact Sciences can help more women with early-stage breast …

View Post

Older Age Should Not Rule Out Chemo in Breast Cancer Patients

In Clinical Studies News by Barbara Jacoby

By: Leah Lawrence, Contributing Writer From: medpagetoday.com Elderly women benefitted from undergoing adjuvant chemotherapy for their node-positive, estrogen receptor-positive breast cancer, even in the presence of multiple comorbidities, retrospective data suggested. A large study of 1,592 patients in the U.S. National Cancer Database from 2010 to 2014 showed that after adjustment for other risk factors, women ages 70 and older …